Literature DB >> 7890124

Bilateral spastic cerebral palsy--a collaborative study between southwest Germany and western Sweden. III: Aetiology.

I Krägeloh-Mann1, G Hagberg, C Meisner, G Haas, K E Eeg-Olofsson, H K Selbmann, B Hagberg, R Michaelis.   

Abstract

In this third report from the collaborative study of children with bilateral spastic cerebral palsy born between 1975 and 1986, aetiology was analysed. Evidence for a prenatal aetiology increased with gestational age, whereas evidence for a peri-/neonatal aetiology decreased. The largest subgroup, the leg-dominated subtype, showed the same distribution of aetiology as the total group. A prenatal aetiology was found mainly among term and moderately preterm children with a four-limb-dominated subtype; a peri-/neonatal aetiology among very preterm children with a three- or four-limb-dominated subtype or among term children with a dyskinetic-spastic subtype. The findings support the hypothesis generated from the authors' epidemiological results of a peri-/neonatal aetiology being predominant among preterm, and a prenatal aetiology among term, children with bilateral spastic cerebral palsy.

Entities:  

Mesh:

Year:  1995        PMID: 7890124     DOI: 10.1111/j.1469-8749.1995.tb11992.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  The changing epidemiology of cerebral palsy.

Authors:  P O Pharoah; M J Platt; T Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-11       Impact factor: 5.747

2.  Prevalence of cerebral palsy in The Netherlands (1977-1988).

Authors:  M J Wichers; Y T van der Schouw; K G Moons; H J Stam; O van Nieuwenhuizen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  At-Home Orthodontic Treatment for Severe Teeth Arch Malalignment and Severe Obstructive Sleep Apnea Syndrome in a Child with Cerebral Palsy.

Authors:  Atsuko Tamura; Kohei Yamaguchi; Ryosuke Yanagida; Rie Miyata; Haruka Tohara
Journal:  Int J Environ Res Public Health       Date:  2022-04-27       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.